MARKET

RXRX

RXRX

Recursion Pharmaceuticals, Inc.
NASDAQ
9.36
-0.15
-1.58%
After Hours: 9.39 +0.03 +0.32% 16:41 05/22 EDT
OPEN
9.52
PREV CLOSE
9.51
HIGH
9.56
LOW
9.22
VOLUME
3.51M
TURNOVER
0
52 WEEK HIGH
16.75
52 WEEK LOW
4.970
MARKET CAP
2.22B
P/E (TTM)
-5.7831
1D
5D
1M
3M
1Y
5Y
Revenues Not Telling The Story For Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) After Shares Rise 25%
Recursion Pharmaceuticals, Inc. Shares have rebounded 25% in the last 30 days. The company's price-to-sales ratio is higher than most of its industry peers. The revenue growth for the company has been going backwards for the past year. The share price of the company is sending bearish signals with a high P/S ratio.
Simply Wall St · 10h ago
Weekly Report: what happened at RXRX last week (0513-0517)?
Weekly Report · 2d ago
LIVE MARKETS-Healthcare to swim along as AI rally broadens
Healthcare to swim along as AI rally broadens Main . Indexes mixed, little changed Energy leads S&P 500 sector gainers; Tech weakest group. Morgan Stanley believes AI and machine-learning integration in biopharma could boost discovery and clinical development of drugs.
Reuters · 5d ago
What's the Difference Between Biotech Stocks and TechBio Stocks?
There's a new trend of companies calling themselves "TechBio" rather than "biotech" to emphasize the role of information technology. TechBio proposes a new way of developing new drugs that uses advanced technologies like AI and robotics. Investors should pay attention to companies like TechBio, but don't invest in them yet.
The Motley Fool · 05/15 12:45
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
Sony Group Corporation shares rose sharply during Tuesday's session after the company reported better-than-expected quarterly financial results. The Dow Jones gained around 20 points on Tuesday. AMC Entertainment Holdings, Inc. Shares rose 78% on Monday after the return of 'Roaring Kitty' to social media. The company's stock jumped over 74% to $.
Benzinga · 05/14 15:01
Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX)
TipRanks · 05/14 11:40
Recursion Pharmaceuticals Stock Surges 10% As Nvidia-Powered Supercomputer Completion Sparks Investor Optimism
Benzinga · 05/13 20:51
Monday's ETF Movers: ARKG, SIL
NASDAQ · 05/13 18:01
More
About RXRX
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate in silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881 and REC-3964. REC-994 is an orally bioavailable, superoxide scavenger small molecule being development for the treatment of symptomatic cerebral cavernous malformation (CCM). REC-2282 for the potential treatment of neurofibromatosis type 2. REC-3964 for the prevention of recurrent Clostridioides difficile infection.

Webull offers Recursion Pharmaceuticals Inc stock information, including NASDAQ: RXRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RXRX stock methods without spending real money on the virtual paper trading platform.